Carbimazole inhibits TNF-α expression in Fat-induced hypothyroidism

0Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The effect of the carbimazole on expression of tumor necrosis factor (TNF-α) in liver, was investigated in an experimental model of high fat diet (HFD) induced obesity. The HFD (orally given for 4 months) induced TNF-α in liver tissue along with raised serum triglyceride (TG), cholesterol and high TSH (62%) In carbimazole (1 mg/100gbw) treatment, the induction of TNF-α was significantly inhibited, without affecting other parameters. It also improved the liver function, which was raised due to HFD in experimental control rats.

References Powered by Scopus

Mechanisms of obesity-associated insulin resistance: Many choices on the menu

613Citations
N/AReaders
Get full text

Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity

436Citations
N/AReaders
Get full text

Obesity, inflammation, and cardiovascular risk

337Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Tripathi, Y. B., & Pandey, N. (2014). Carbimazole inhibits TNF-α expression in Fat-induced hypothyroidism. Journal of Diabetes and Metabolic Disorders, 13(1). https://doi.org/10.1186/s40200-014-0083-4

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 4

67%

Lecturer / Post doc 1

17%

Researcher 1

17%

Readers' Discipline

Tooltip

Medicine and Dentistry 2

40%

Pharmacology, Toxicology and Pharmaceut... 1

20%

Nursing and Health Professions 1

20%

Social Sciences 1

20%

Save time finding and organizing research with Mendeley

Sign up for free